IONIS-GCCRRx, also known as ISIS-426115, is an antiglucocorticoid which is under development by Ionis Pharmaceuticals (formerly Isis Pharmaceuticals)... 3 KB (128 words) - 21:22, 1 December 2023 |
 | 3021–012 RTI 3021–022 Telapristone Tibolone Toripristone Ulipristal acetate Zavacorilant Others Antisense oligonucleotides: IONIS-GCCRRx (ISIS-426115)... 13 KB (878 words) - 12:39, 25 April 2024 |
 | 3021–012 RTI 3021–022 Telapristone Tibolone Toripristone Ulipristal acetate Zavacorilant Others Antisense oligonucleotides: IONIS-GCCRRx (ISIS-426115)... 6 KB (280 words) - 05:07, 18 January 2024 |
 | 3021–012 RTI 3021–022 Telapristone Tibolone Toripristone Ulipristal acetate Zavacorilant Others Antisense oligonucleotides: IONIS-GCCRRx (ISIS-426115)... 4 KB (240 words) - 13:42, 1 November 2023 |
 | 3021–012 RTI 3021–022 Telapristone Tibolone Toripristone Ulipristal acetate Zavacorilant Others Antisense oligonucleotides: IONIS-GCCRRx (ISIS-426115)... 10 KB (806 words) - 02:27, 4 March 2024 |
 | 3021–012 RTI 3021–022 Telapristone Tibolone Toripristone Ulipristal acetate Zavacorilant Others Antisense oligonucleotides: IONIS-GCCRRx (ISIS-426115)... 17 KB (1,036 words) - 04:19, 14 April 2024 |
 | 3021–012 RTI 3021–022 Telapristone Tibolone Toripristone Ulipristal acetate Zavacorilant Others Antisense oligonucleotides: IONIS-GCCRRx (ISIS-426115)... 16 KB (1,509 words) - 14:16, 24 December 2023 |
 | 3021–012 RTI 3021–022 Telapristone Tibolone Toripristone Ulipristal acetate Zavacorilant Others Antisense oligonucleotides: IONIS-GCCRRx (ISIS-426115)... 16 KB (1,237 words) - 18:41, 17 March 2024 |
 | 3021–012 RTI 3021–022 Telapristone Tibolone Toripristone Ulipristal acetate Zavacorilant Others Antisense oligonucleotides: IONIS-GCCRRx (ISIS-426115)... 3 KB (108 words) - 03:59, 24 February 2024 |
 | 3021–012 RTI 3021–022 Telapristone Tibolone Toripristone Ulipristal acetate Zavacorilant Others Antisense oligonucleotides: IONIS-GCCRRx (ISIS-426115)... 38 KB (3,032 words) - 04:47, 30 April 2024 |